{"prompt": "['OSTPDL1', 'Page 30 of 60', 'v4.03)', 'Grade 1', 'Continue avelumab', 'Close monitoring for', 'Diarrhea: < 4 stools/day', 'therapy', 'worsening symptoms', 'over baseline', 'Symptomatic treatment', 'Educate participant to', 'Colitis: asymptomatic', '(e.g. loperamide)', 'report worsening', 'immediately', 'If worsens: treat as Grade', '2 or 3 to 4.', 'Grade 2', 'Delay avelumab therapy', 'If improves to Grade 1', 'Diarrhea: 4 to 6', 'Symptomatic treatment', 'within 7 days, resume', 'stools/day over baseline;', 'avelumab therapy', 'IV fluids indicated < 24', 'If persists > 5 to 7 days or', 'hours, not interfering with', 'recur: 0.5-1.0 - mg/kg/day', 'ADLs', 'methylprednisolone (or', 'Colitis: abdominal pain,', 'equivalent).', 'blood in stool', 'When symptoms improve', 'to Grade 1, taper steroids', 'over at least 1 month.', 'Consider prophylactic', 'antibiotics for', 'opportunistic infections,', 'and resume avelumab', 'therapy per protocol.', 'If worsens or persists > 3', 'to 5 days with oral', 'steroids: treat as grade 3', 'to 4', 'Grade 3 to 4', 'Discontinue avelumab', 'If improves:', 'Diarrhea (Grade 3): 7', 'therapy per protocol', 'continue steroids until', 'stools/ day over baseline;', 'Start 1.0-2.0 mg/kg/day', 'Grade 1, then taper over at', 'incontinence; IV fluids', 'methylprednisolone IV', 'least 1 month', '24 hours; interfering with', '(or equivalent)', 'If persists > 3 to 5 days or', 'ADLs', 'Add prophylactic', 'recurs after improvement:', 'Colitis (Grade 3): severe', 'antibiotics for', 'Add infliximab 5 mg/kg', 'abdominal pain, medical', 'opportunistic infections', 'unless otherwise', 'intervention indicated,', 'Consider endoscopy', 'contraindicated (note:', 'peritoneal signs', 'infliximab should not be', 'Grade 4: life-threatening,', 'used in cases of', 'perforation', 'perforation or sepsis)', 'Dermatological irAEs', 'Grade of Rash', '(NCI-CTCAE v4)', 'Management', 'Follow-up', 'Grade 1 to 2', 'Symptomatic therapy (for', 'If persists > 1 to 2 weeks', 'Covering < 30% body', 'example, antihistamines,', 'or recurs:', 'surface area', 'topical steroids)', 'Consider s.kin biopsy', 'St. Fude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-201 APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']['OSTPDL1', 'Page 31 of 60', 'Continue avelumab', 'Delay avelumab therapy', 'therapy', 'Consider 0.5 to 1.0', 'mg/kg/day', 'methylprednisolone IV or', 'oral equivalent. Once', 'improving, taper steroids', 'over at least 1 month,', 'consider prophylactic', 'antibiotics for', 'opportunistic infections,', 'and resume avelumab', 'therapy.', 'If worsens:', 'Treat as Grade 3 to 4', 'Grade 3 to 4', 'Delay or discontinue', 'If improves to Grade 1:', 'Covering > 30% body', 'avelumab therapy', 'Taper steroids over at', 'surface area; life-', 'Consider skin biopsy', 'least 1 month and add', 'threatening consequences', 'Dermatology consult', 'prophylactic antibiotics', '1.0 to 2.0 mg/kg/day', 'for opportunistic', 'methylprednisolone IV or', 'infections.', 'IV equivalent', 'Resume avelumab therapy', 'Pulmonary irAEs', 'Grade of Pneumonitis', 'Management', 'Follow-up', '(NCI-CTCAE v4)', 'Grade 1', 'Consider delay of', 'Re-image at least every 3', '(Radiographic changes', 'avelumab therapy', 'weeks If worsens:', 'only)', 'Monitor for symptoms', 'Treat as Grade 2 or Grade', 'every 2 to 3 days', '3 to 4', 'Consider Pulmonary and', 'Infectious Disease', 'consults', 'Grade 2', 'Delay avelumab therapy', 'Re-image every 1 to 3', '(Mild to moderate new', 'Pulmonary and Infectious', 'days', 'symptoms)', 'Disease consults', 'If improves:', 'Monitor symptoms daily,', 'When symptoms return to', 'consider hospitalization', 'near baseline, taper', '1 mg/kg/day', 'steroids over at least 1', 'methylprednisolone IV or', 'month and then resume', 'oral equivalent', 'avelumab therapy and', 'Consider bronchoscopy,', 'consider prophylactic', 'lung biopsy', 'antibiotics', 'If not improving after 2', 'weeks or worsening:', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']\n\n###\n\n", "completion": "END"}